All Stories

  1. Heritability of a resting heart rate in a 20-year follow-up family cohort with GWAS data: Insights from the STANISLAS cohort

    Article • European Journal of Preventive Cardiology, December 2019, SAGE Publications

    Dr Joao Pedro Ferreira

  2. Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study

    Article • European Journal of Heart Failure, December 2019, Wiley

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  3. Income level and inequality as complement to geographical differences in cardiovascular trials

    Article • American Heart Journal, December 2019, Elsevier

    Dr Joao Pedro Ferreira

  4. MRAs in Elderly HF Patients

    Article • JACC Heart Failure, December 2019, Elsevier

    Dr Joao Pedro Ferreira

  5. Bioprofiles and mechanistic pathways associated with Cheyne-Stokes respiration: insights from the SERVE-HF trial

    Article • Clinical Research in Cardiology, November 2019, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  6. Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF

    Article • European Journal of Internal Medicine, November 2019, Elsevier

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  7. Renin-angiotensin-aldosterone system and kidney interactions in heart failure

    Article • Journal of the Renin-Angiotensin-Aldosterone System, October 2019, SAGE Publications

    Dr Joao Pedro Ferreira

  8. Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction

    Article • Journal of Hypertension, October 2019, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  9. Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial

    Article • Clinical Cardiology, September 2019, Wiley

    Dr Joao Pedro Ferreira

  10. World Heart Federation Roadmap for Heart Failure

    Article • Global Heart, September 2019, Elsevier

    Dr Joao Pedro Ferreira

  11. Heart failure around the world

    Article • European Journal of Heart Failure, August 2019, Wiley

    Dr Joao Pedro Ferreira

  12. Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure

    Article • International Journal of Cardiology, August 2019, Elsevier

    Dr Joao Pedro Ferreira

  13. External Validation of the ELAN‐HF Score, Predicting 6‐Month All‐Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure

    Article • Journal of the American Heart Association, July 2019, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  14. Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with A...

    Article • Clinical Research in Cardiology, June 2019, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  15. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

    Article • European Heart Journal, June 2019, Oxford University Press (OUP)

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  16. Chest X-ray quantification of admission lung congestion as a prognostic factor in patients admitted for worsening heart failure from the ICALOR cohort study

    Article • International Journal of Cardiology, June 2019, Elsevier

    Dr Joao Pedro Ferreira

  17. Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case–control analyses

    Article • Clinical Research in Cardiology, May 2019, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  18. Estimated Long-Term Survival With Eplerenone

    Article • Journal of the American College of Cardiology, May 2019, Elsevier

    Dr Joao Pedro Ferreira

  19. Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure

    Article • Circulation Heart Failure, May 2019, Wolters Kluwer Health

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  20. Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative

    Article • Clinical Research in Cardiology, April 2019, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  21. Income Inequality and Outcomes in Heart Failure

    Article • JACC Heart Failure, April 2019, Elsevier

    Dr Joao Pedro Ferreira

  22. Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS‐HF trial

    Article • European Journal of Heart Failure, February 2019, Wiley

    Dr Joao Pedro Ferreira

  23. Empagliflozin reduces the risk of a broad spectrum of heart failure outcomes regardless of heart failure status at baseline

    Article • European Journal of Heart Failure, February 2019, Wiley

    Dr Joao Pedro Ferreira

  24. Nondipping Pattern and Cardiovascular and Renal Damage in a Population-Based Study (The STANISLAS Cohort Study)

    Article • American Journal of Hypertension, February 2019, Oxford University Press (OUP)

    Dr Joao Pedro Ferreira

  25. Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developments

    Article • European Heart Journal Supplements, February 2019, Oxford University Press (OUP)

    Dr Joao Pedro Ferreira

  26. Is Sacubitril/Valsartan Antifibrotic?

    Article • Journal of the American College of Cardiology, February 2019, Elsevier

    Dr Joao Pedro Ferreira

  27. Balancing Benefits and Risks of Spironolactone in HFpEF and Chronic Kidney Disease Patients

    Article • JACC Heart Failure, January 2019, Elsevier

    Dr Joao Pedro Ferreira

  28. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study

    Article • European Journal of Heart Failure, January 2019, Wiley

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  29. Extracting Meaning of Tubular Injury Molecules: Implications for Cardiorenal Health

    Article • American Journal of Nephrology, January 2019, Karger Publishers

    Dr Joao Pedro Ferreira

  30. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study

    Article • Nephrology Dialysis Transplantation, December 2018, Oxford University Press (OUP)

    Dr Joao Pedro Ferreira

  31. Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study

    Article • ESC Heart Failure, November 2018, Wiley

    Dr Joao Pedro Ferreira

  32. Correction to: Prognostic value of estimated plasma volume in acute heart failure in three cohort studies

    Article • Clinical Research in Cardiology, November 2018, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  33. Survival after bilateral internal mammary artery in coronary artery bypass grafting: Are women at risk?

    Article • International Journal of Cardiology, November 2018, Elsevier

    Dr Joao Pedro Ferreira

  34. Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study

    Article • European Journal of Heart Failure, October 2018, Wiley

    Dr Joao Pedro Ferreira

  35. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies

    Article • Clinical Research in Cardiology, October 2018, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  36. Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?

    Article • European Journal of Heart Failure, October 2018, Wiley

    Dr Joao Pedro Ferreira

  37. Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus

    Article • JACC Heart Failure, October 2018, Elsevier

    Dr Joao Pedro Ferreira

  38. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points

    Article • Circulation Cardiovascular Quality and Outcomes, October 2018, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  39. Editor’s Choice- Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction

    Article • European Heart Journal Acute Cardiovascular Care, September 2018, SAGE Publications

    Professor Faiez zannad, Dr Joao Pedro Ferreira

  40. Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial

    Article • Clinical Research in Cardiology, September 2018, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  41. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials

    Article • Clinical Research in Cardiology, September 2018, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  42. Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure

    Article • Heart, August 2018, BMJ

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  43. Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure

    Article • Journal of Hypertension, August 2018, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  44. Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns

    Article • Circulation Heart Failure, July 2018, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  45. Association between abdominal adiposity and 20-year subsequent aortic stiffness in an initially healthy population-based cohort

    Article • Journal of Hypertension, June 2018, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  46. Fibrosis mechanistic phenotyping and antifibrotic response determination with biomarkers in heart failure: one single biomarker may not fit all settings

    Article • European Journal of Heart Failure, May 2018, Wiley

    Dr Joao Pedro Ferreira

  47. Obesity and metabolic features associated with long-term developing diastolic dysfunction in an initially healthy population-based cohort

    Article • Clinical Research in Cardiology, April 2018, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  48. Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (From the High-Risk Myocardial Infarction Database Initiative)

    Article • The American Journal of Cardiology, February 2018, Elsevier

    Dr Joao Pedro Ferreira

  49. Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation

    Article • Journal of the American College of Cardiology, February 2018, Elsevier

    Dr Joao Pedro Ferreira

  50. Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction

    Article • European Journal of Heart Failure, January 2018, Wiley

    Dr Joao Pedro Ferreira

  51. NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial

    Article • Circulation, December 2017, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  52. Cohort Profile: Rationale and design of the fourth visit of the STANISLAS Cohort: a familial longitudinal population-based cohort from the Nancy region of France

    Article • International Journal of Epidemiology, December 2017, Oxford University Press (OUP)

    Dr Joao Pedro Ferreira

  53. Interpretation of the ATHENA Trial—Caveats and Future Directions

    Article • JAMA Cardiology, December 2017, American Medical Association (AMA)

    Dr Joao Pedro Ferreira

  54. Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

    Article • ESC Heart Failure, October 2017, Wiley

    Dr Joao Pedro Ferreira, Professor Javier Diez

  55. Practical management of concomitant acute heart failure and worsening renal function in the emergency department

    Article • European Journal of Emergency Medicine, October 2017, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  56. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure

    Article • Journal of the American College of Cardiology, October 2017, Elsevier

    Dr Joao Pedro Ferreira

  57. Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study

    Article • Clinical Research in Cardiology, August 2017, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  58. Coronary angiography in worsening heart failure: determinants, findings and prognostic implications

    Article • Heart, August 2017, BMJ

    Dr Joao Pedro Ferreira, Professor John GF Cleland

  59. Individualizing treatment choices in the systolic blood pressure intervention trial

    Article • Journal of Hypertension, August 2017, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  60. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF

    Article • European Journal of Heart Failure, June 2017, Wiley

    Dr Joao Pedro Ferreira

  61. Risk for Incident Heart Failure: A Subject‐Level Meta‐Analysis From the Heart “OMics” in AGEing (HOMAGE) Study

    Article • Journal of the American Heart Association, May 2017, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  62. Reply

    Article • Journal of the American College of Cardiology, May 2017, Elsevier

    Dr Joao Pedro Ferreira

  63. Hyperkalaemia prevalence, recurrence and management in chronic haemodialysis: a prospective multicentre French regional registry 2-year survey

    Article • Nephrology Dialysis Transplantation, April 2017, Oxford University Press (OUP)

    Dr Joao Pedro Ferreira

  64. Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?

    Article • European Journal of Heart Failure, April 2017, Wiley

    Dr Joao Pedro Ferreira

  65. Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study

    Article • Journal of the American Medical Directors Association, March 2017, Elsevier

    Dr Joao Pedro Ferreira

  66. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE

    Article • Circulation Heart Failure, February 2017, Wolters Kluwer Health

    Dr Joao Pedro Ferreira, Professor john j mcmurray

  67. Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality

    Article • Cardiorenal Medicine, January 2017, Karger Publishers

    Dr Joao Pedro Ferreira

  68. High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60

    Article • American Journal of Nephrology, November 2016, Karger Publishers

    Dr Joao Pedro Ferreira

  69. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and Heart Failure

    Article • JACC Heart Failure, November 2016, Elsevier

    Dr Joao Pedro Ferreira

  70. Association of beta‐blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched‐cohort analysis from the High‐Risk Myoca...

    Article • European Journal of Heart Failure, October 2016, Wiley

    Dr Joao Pedro Ferreira

  71. A tentative interpretation of the TOPCAT trial based on randomized evidence from the brain natriuretic peptide stratum analysis

    Article • European Journal of Heart Failure, September 2016, Wiley

    Dr Joao Pedro Ferreira

  72. Intima–Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population‐Based Cohort (STANISLAS Cohort Study)

    Article • Journal of the American Heart Association, June 2016, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  73. Enlarging Red Blood Cell Distribution Width During Hospitalization Identifies a Very High-Risk Subset of Acutely Decompensated Heart Failure Patients and Adds Valuable Prognostic Information on Top of Hemoconcentration

    Article • Medicine, April 2016, Wolters Kluwer Health

    Dr Joao Pedro Ferreira

  74. Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation

    Article • European Journal of Heart Failure, February 2016, Wiley

    Dr Béatrice Brembilla-Perrot, Dr Joao Pedro Ferreira

  75. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect

    Article • Clinical Research in Cardiology, November 2015, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  76. To the Editor— Diabetes and sudden death: Let’s assess the absolute risk increase rather than the proportional risk from sudden cardiac death!

    Article • Heart Rhythm, November 2015, Elsevier

    Dr Joao Pedro Ferreira

  77. A Systematic Assessment of Absolute Treatment Effect

    Article • The American Journal of Cardiology, September 2015, Elsevier

    Dr Joao Pedro Ferreira

  78. Geographic differences in heart failure trials

    Article • European Journal of Heart Failure, July 2015, Wiley

    Dr Joao Pedro Ferreira

  79. Oxygen therapy: a clinical audit in an Internal Medicine Department

    Article • Revista Portuguesa de Pneumologia (English Edition), March 2015, Elsevier

    Dr Joao Pedro Ferreira

  80. Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice

    Article • International Journal of Molecular Sciences, January 2015, MDPI AG

    Dr Joao Pedro Ferreira

  81. High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure

    Article • Cor et Vasa, December 2014, Elsevier

    Dr Joao Pedro Ferreira

  82. The role of albuminuria as a non-invasive marker for congestive acutely decompensated chronic heart failure and the spironolactone effect in elderly Portuguese: a non-randomized trial

    Article • Nephrology, February 2014, Wiley

    Dr Joao Pedro Ferreira

  83. Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure

    Article • European Journal of Internal Medicine, January 2014, Elsevier

    Dr Joao Pedro Ferreira

  84. High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients

    Article • Cardiology Research and Practice, January 2014, Hindawi Publishing Corporation

    Dr Joao Pedro Ferreira

  85. Influence of Spironolactone on Matrix Metalloproteinase-2 in Acute Decompensated Heart Failure

    Article • Arquivos Brasileiros de Cardiologia, January 2014, GN1 Genesis Network

    Dr Joao Pedro Ferreira

  86. Left-sided infective endocarditis: Analysis of in-hospital and medium-term outcome and predictors of mortality

    Article • Revista Portuguesa de Cardiologia, October 2013, Elsevier

    Dr Joao Pedro Ferreira

  87. Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors

    Article • Clinical Research in Cardiology, July 2013, Springer Science + Business Media

    Dr Joao Pedro Ferreira

  88. Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma

    Article • ISRN Rheumatology, January 2012, Hindawi Publishing Corporation

    Dr Joao Pedro Ferreira

  89. Investigating a Case of Recurrent Pleural Effusion

    Article • Case Reports in Pulmonology, January 2011, Hindawi Publishing Corporation

    Dr Joao Pedro Ferreira